The main goals are:
1. Identify appropriate standards for capturing the patient perspective when measuring health outcomes and patients’ experience of healthcare, and obtain support for these standards among relevant stakeholders.
2. Implement appropriate technology solutions (including adopting existing technology where appropriate) that would allow individual patients to record and measure their outcomes according to these standards and use the information for a more structured dialogue with their HCPs.
3. Establish the appropriate platform to collect, process and manage data in the best interest of patients, patient organisations, health authorities, healthcare professionals, the research community and health care payers.
4. Create a sustainable, socially acceptable and ethical model for the continuous collection of data and an appropriate model for providing access to the identifiable or anonymised or aggregated data to researchers with a legitimate interest in analysing them.
These goals can be achieved through the creation of health outcomes observatories in three selected disease areas: diabetes type 1 and 2, inflammatory bowel disease and cancer (side effects of chemotherapy and immune-oncology). The observatories will collect health data in at least three different European countries for each disease area.
1. Patient outcomes and their experience of healthcare, and thus their overall care, could be improved through systematic capture of the patient voice and perspective.
It is important to complement existing clinical outcome measurements with patient-generated measures of disease and health-related quality of life (HRQOL) to ensure that the patient perspective of disease and the impact of healthcare interventions are more completely captured and that disease heterogeneity is better understood.
In order to achieve this, it is essential to provide patients with tools that have the ability to better capture the entirety of the impact of a disease and treatments (e.g. signs, symptoms, tolerability), allowing them to document their disease more completely and in a structured manner. To be effective, these tools should be built on the basis of accepted standards, developed in partnership with all relevant stakeholders and accepted and integrated into the existing healthcare ecosystem.
2. A reward system that truly focuses on value requires measurement and transparency of patient outcomes.
At the level of the individual patient, the data generated, once structured and subjected to a degree of standardisation, will enable patients to have more productive interactions with their healthcare provider. At the level of the healthcare system, this data will allow a systematic measurement of health outcomes and the possibility to set up a reward system based on value – which can be defined as the level of health outcomes achieved for a given cost.
3. There is a lack of models for capturing and managing patient-reported health data in an ethical and sustainable way.
Structured health data is invaluable for all stakeholders, from the individual patient, healthcare professionals (HCPs), the life science industry, and policy makers to the patient advocacy groups. There have been a few successful examples of approaches to integrate patient-reported health data into clinical care. In an era of greater focus on the patient, it is thus critical for a society that patient-reported health and experience data is captured and managed in an ethical manner ensuring broad and appropriate access while safeguarding patients’ privacy and building high levels of trust.
1. Enable individual patients to:
- receive close to real-time information on their disease status;
- hold more informed discussions with healthcare professionals about their health status and options;
- better understand how their status compares with other patients with a similar condition;
- share their data and help the broader patient community.
2. Allow healthcare professionals to:
- track the evolution of their patients;
- enable a different outcome-based conversation;
- better inform and enhance clinical decisions based on the patient perspective.
3. Allow patient organisations to:
- assess the status and dynamics of their patient population;
- increase engagement with other healthcare stakeholders in evidence-based advocacy;
- further contribute to improving the healthcare system.
4. Allow health authorities and healthcare providers to:
- improve the quality of care through better and more transparent evidence of patient measures and outcomes;
- drive research agendas and investments in the right areas;
- ensure the sustainability of healthcare systems in finding ways to improve the allocation of resources.
5. Allow pharmaceutical companies and other innovative companies to use data to:
- enable ethical utilisation of the observatory data as legally appropriate;
- generate insights that can be used to support the design and direction of the development of new treatments;
- generate robust evidence that can be used in submissions to regulators, health technology assessment (HTA) agencies and other decision makers.